# Snowflake Inc.: financial statements, quarterly

SNOW · NYSE · CIK 1640147 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/snow.md) · [Financials](/companies/snow/financials.md) · [Filings](/companies/snow/filings.md) · [Insiders](/companies/snow/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/snow/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [734](/filings/0001640147-24-000250.md) | [775 d](/filings/0001640147-26-000008.md) | [829](/filings/0001640147-25-000110.md) | [869](/filings/0001640147-25-000187.md) | [942](/filings/0001640147-25-000211.md) | [987 d](/filings/0001640147-26-000008.md) | [1,042](/filings/0001640147-26-000030.md) | [1,145](/filings/0001640147-26-000037.md) | [1,213](/filings/0001640147-25-000211.md) | [1,284 d](/filings/0001640147-26-000008.md) | [1,391](/filings/0001640147-26-000030.md) | [1,547](/filings/0001640147-26-000037.md) |
| Cost of revenue | $m | [229](/filings/0001640147-24-000250.md) | [242 d](/filings/0001640147-26-000008.md) | [273](/filings/0001640147-25-000110.md) | [288](/filings/0001640147-25-000187.md) | [321](/filings/0001640147-25-000211.md) | [333 d](/filings/0001640147-26-000008.md) | [349](/filings/0001640147-26-000030.md) | [372](/filings/0001640147-26-000037.md) | [391](/filings/0001640147-25-000211.md) | [426 d](/filings/0001640147-26-000008.md) | [465](/filings/0001640147-26-000030.md) | [510](/filings/0001640147-26-000037.md) |
| Gross profit | $m | [505](/filings/0001640147-24-000250.md) | [533 d](/filings/0001640147-26-000008.md) | [556](/filings/0001640147-25-000110.md) | [581](/filings/0001640147-25-000187.md) | [621](/filings/0001640147-25-000211.md) | [654 d](/filings/0001640147-26-000008.md) | [693](/filings/0001640147-26-000030.md) | [773](/filings/0001640147-26-000037.md) | [822](/filings/0001640147-25-000211.md) | [858 d](/filings/0001640147-26-000008.md) | [926](/filings/0001640147-26-000030.md) | [1,037](/filings/0001640147-26-000037.md) |
| Research and development | $m | [332](/filings/0001640147-24-000250.md) | [364 d](/filings/0001640147-26-000008.md) | [411](/filings/0001640147-25-000110.md) | [438](/filings/0001640147-25-000187.md) | [442](/filings/0001640147-25-000211.md) | [492 d](/filings/0001640147-26-000008.md) | [472](/filings/0001640147-26-000030.md) | [492](/filings/0001640147-26-000037.md) | [494](/filings/0001640147-25-000211.md) | [511 d](/filings/0001640147-26-000008.md) | [535](/filings/0001640147-26-000030.md) | [567](/filings/0001640147-26-000037.md) |
| Operating income | $m | [(261)](/filings/0001640147-24-000250.md) | [(276) d](/filings/0001640147-26-000008.md) | [(349)](/filings/0001640147-25-000110.md) | [(355)](/filings/0001640147-25-000187.md) | [(365)](/filings/0001640147-25-000211.md) | [(387) d](/filings/0001640147-26-000008.md) | [(447)](/filings/0001640147-26-000030.md) | [(340)](/filings/0001640147-26-000037.md) | [(329)](/filings/0001640147-25-000211.md) | [(318) d](/filings/0001640147-26-000008.md) | [(326)](/filings/0001640147-26-000030.md) | [(263)](/filings/0001640147-26-000037.md) |
| Interest expense | $m | [0.0](/filings/0001640147-24-000250.md) | [0.0 d](/filings/0001640147-26-000008.md) | [0.0](/filings/0001640147-25-000110.md) | [0.0](/filings/0001640147-25-000187.md) | [0.7](/filings/0001640147-25-000211.md) | [2.1 d](/filings/0001640147-26-000008.md) | [2.1](/filings/0001640147-26-000030.md) | [2.1](/filings/0001640147-26-000037.md) | [2.1](/filings/0001640147-25-000211.md) | [2.1 d](/filings/0001640147-26-000008.md) | [2.1](/filings/0001640147-26-000030.md) | [2.1](/filings/0001640147-26-000037.md) |
| Income tax | $m | [3.4](/filings/0001640147-24-000250.md) | [(4.3) d](/filings/0001640147-26-000008.md) | [2.7](/filings/0001640147-25-000110.md) | [3.8](/filings/0001640147-25-000187.md) | [1.9](/filings/0001640147-25-000211.md) | [(4.3) d](/filings/0001640147-26-000008.md) | [5.7](/filings/0001640147-26-000030.md) | [0.1](/filings/0001640147-26-000037.md) | [3.7](/filings/0001640147-25-000211.md) | [7.7 d](/filings/0001640147-26-000008.md) | [(1.1)](/filings/0001640147-26-000030.md) | [3.4](/filings/0001640147-26-000037.md) |
| Net income | $m | [(214)](/filings/0001640147-24-000250.md) | [(169) d](/filings/0001640147-26-000008.md) | [(317)](/filings/0001640147-25-000110.md) | [(317)](/filings/0001640147-25-000187.md) | [(324)](/filings/0001640147-25-000211.md) | [(327) d](/filings/0001640147-26-000008.md) | [(430)](/filings/0001640147-26-000030.md) | [(298)](/filings/0001640147-26-000037.md) | [(294)](/filings/0001640147-25-000211.md) | [(310) d](/filings/0001640147-26-000008.md) | [(296)](/filings/0001640147-26-000030.md) | [(192)](/filings/0001640147-26-000037.md) |
| Diluted EPS | $ per share | [(0.65)](/filings/0001640147-24-000250.md) | not reported | [(0.95)](/filings/0001640147-25-000110.md) | [(0.95)](/filings/0001640147-25-000187.md) | [(0.98)](/filings/0001640147-25-000211.md) | not reported | [(1.29)](/filings/0001640147-26-000030.md) | [(0.89)](/filings/0001640147-26-000037.md) | [(0.87)](/filings/0001640147-25-000211.md) | not reported | [(0.86)](/filings/0001640147-26-000030.md) | [(0.55)](/filings/0001640147-26-000037.md) |
| Basic EPS | $ per share | [(0.65)](/filings/0001640147-24-000250.md) | not reported | [(0.95)](/filings/0001640147-25-000110.md) | [(0.95)](/filings/0001640147-25-000187.md) | [(0.98)](/filings/0001640147-25-000211.md) | not reported | [(1.29)](/filings/0001640147-26-000030.md) | [(0.89)](/filings/0001640147-26-000037.md) | [(0.87)](/filings/0001640147-25-000211.md) | not reported | [(0.86)](/filings/0001640147-26-000030.md) | [(0.55)](/filings/0001640147-26-000037.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [982](/filings/0001640147-24-000250.md) | [1,763](/filings/0001640147-26-000008.md) | [1,330](/filings/0001640147-25-000110.md) | [1,282](/filings/0001640147-25-000187.md) | [2,149](/filings/0001640147-25-000211.md) | [2,629](/filings/0001640147-26-000008.md) | [2,243](/filings/0001640147-26-000030.md) | [1,881](/filings/0001640147-26-000037.md) | [1,942](/filings/0001640147-25-000211.md) | [2,828](/filings/0001640147-26-000037.md) | [2,085](/filings/0001640147-26-000030.md) | [1,707](/filings/0001640147-26-000037.md) |
| Current assets | $m | [4,312](/filings/0001640147-23-000260.md) | [5,039](/filings/0001640147-25-000052.md) | [4,143](/filings/0001640147-24-000135.md) | [3,898](/filings/0001640147-24-000207.md) | [4,984](/filings/0001640147-24-000250.md) | [5,869](/filings/0001640147-26-000008.md) | [4,786](/filings/0001640147-25-000110.md) | [4,596](/filings/0001640147-25-000187.md) | [4,623](/filings/0001640147-25-000211.md) | [5,743](/filings/0001640147-26-000037.md) | [3,977](/filings/0001640147-26-000030.md) | [3,494](/filings/0001640147-26-000037.md) |
| Total assets | $m | [7,264](/filings/0001640147-23-000260.md) | [8,223](/filings/0001640147-25-000052.md) | [7,298](/filings/0001640147-24-000135.md) | [6,944](/filings/0001640147-24-000207.md) | [8,202](/filings/0001640147-24-000250.md) | [9,034](/filings/0001640147-26-000008.md) | [8,157](/filings/0001640147-25-000110.md) | [8,197](/filings/0001640147-25-000187.md) | [8,230](/filings/0001640147-25-000211.md) | [9,132](/filings/0001640147-26-000037.md) | [8,554](/filings/0001640147-26-000030.md) | [8,690](/filings/0001640147-26-000037.md) |
| Current liabilities | $m | [2,033](/filings/0001640147-23-000260.md) | [2,731](/filings/0001640147-25-000052.md) | [2,429](/filings/0001640147-24-000135.md) | [2,465](/filings/0001640147-24-000207.md) | [2,647](/filings/0001640147-24-000250.md) | [3,301](/filings/0001640147-26-000008.md) | [3,031](/filings/0001640147-25-000110.md) | [3,096](/filings/0001640147-25-000187.md) | [3,383](/filings/0001640147-25-000211.md) | [4,422](/filings/0001640147-26-000037.md) | [3,777](/filings/0001640147-26-000030.md) | [3,722](/filings/0001640147-26-000037.md) |
| Total liabilities | $m | [2,324](/filings/0001640147-23-000260.md) | [3,033](/filings/0001640147-25-000052.md) | [2,730](/filings/0001640147-24-000135.md) | [2,806](/filings/0001640147-24-000207.md) | [5,268](/filings/0001640147-24-000250.md) | [6,027](/filings/0001640147-26-000008.md) | [5,743](/filings/0001640147-25-000110.md) | [5,817](/filings/0001640147-25-000187.md) | [6,097](/filings/0001640147-25-000211.md) | [7,208](/filings/0001640147-26-000037.md) | [6,615](/filings/0001640147-26-000030.md) | [6,541](/filings/0001640147-26-000037.md) |
| Shareholders' equity | $m | [4,930](/filings/0001640147-23-000260.md) | [5,180](/filings/0001640147-25-000052.md) | [4,558](/filings/0001640147-24-000135.md) | [4,129](/filings/0001640147-24-000207.md) | [2,929](/filings/0001640147-24-000250.md) | [3,000](/filings/0001640147-26-000008.md) | [2,408](/filings/0001640147-25-000110.md) | [2,373](/filings/0001640147-25-000187.md) | [2,133](/filings/0001640147-25-000211.md) | [1,924](/filings/0001640147-26-000008.md) | [1,940](/filings/0001640147-26-000037.md) | [2,150](/filings/0001640147-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [121 d](/filings/0001640147-24-000250.md) | [345 d](/filings/0001640147-26-000008.md) | [355](/filings/0001640147-25-000110.md) | [69.9 d](/filings/0001640147-25-000187.md) | [102 d](/filings/0001640147-25-000211.md) | [433 d](/filings/0001640147-26-000008.md) | [228](/filings/0001640147-26-000030.md) | [74.9 d](/filings/0001640147-26-000037.md) | [138 d](/filings/0001640147-25-000211.md) | [781 d](/filings/0001640147-26-000008.md) | [243](/filings/0001640147-26-000030.md) | [91.4 d](/filings/0001640147-26-000037.md) |
| Capital expenditure | $m | [8.7 d](/filings/0001640147-24-000250.md) | [13.1 d](/filings/0001640147-26-000008.md) | [16.5](/filings/0001640147-25-000110.md) | [5.0 d](/filings/0001640147-25-000187.md) | [13.4 d](/filings/0001640147-25-000211.md) | [11.3 d](/filings/0001640147-26-000008.md) | [45.0](/filings/0001640147-26-000030.md) | [16.7 d](/filings/0001640147-26-000037.md) | [23.9 d](/filings/0001640147-25-000211.md) | [16.1 d](/filings/0001640147-26-000008.md) | [10.5](/filings/0001640147-26-000030.md) | [7.6 d](/filings/0001640147-26-000037.md) |
| Share repurchases | $m | [400](/filings/0001640147-23-000260.md) | [0.0 d](/filings/0001640147-26-000008.md) | [516](/filings/0001640147-25-000110.md) | [400](/filings/0001640147-24-000207.md) | [1,016 d](/filings/0001640147-25-000211.md) | [0.0 d](/filings/0001640147-26-000008.md) | [491](/filings/0001640147-26-000030.md) | [0.0 d](/filings/0001640147-26-000037.md) | [233 d](/filings/0001640147-25-000211.md) | [150 d](/filings/0001640147-26-000008.md) | [300](/filings/0001640147-26-000030.md) | [0.0 d](/filings/0001640147-26-000037.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-07-31) | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [318](/filings/0001640147-23-000199.md) | [320](/filings/0001640147-23-000260.md) | [324](/filings/0001640147-23-000102.md) | [327](/filings/0001640147-23-000199.md) | [329](/filings/0001640147-23-000260.md) | [334](/filings/0001640147-25-000187.md) | [332](/filings/0001640147-25-000211.md) | [333](/filings/0001640147-26-000030.md) | [335](/filings/0001640147-26-000037.md) | [340](/filings/0001640147-25-000211.md) | [345](/filings/0001640147-26-000030.md) | [349](/filings/0001640147-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 352,800,000 at 2026-08-21, from the cover of the [10-Q filed 2026-09-04](/filings/0001640147-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.